Michael Martin

Takeda Ventures thesis

Takeda Ventures, Inc. is the corporate venture capital group of Takeda, and was founded in 2001 with the vision of generating disruptive technologies and therapeutic solutions for patients through venture-based investments. Takeda Ventures focuses on high-caliber, therapeutic, platform-based companies around the world. We specifically invest in early-stage, preclinical opportunities and products which complement Takeda’s pipeline with the mission to create strategic growth opportunities for Takeda through building, managing and investing in innovative companies. Takeda Ventures partners with a

Sector and stage focus

• Seed: Pharmaceuticals
• Series B: Pharmaceuticals
• Series A: Pharmaceuticals
• general: Los Angeles / Southern California

Is Michael Martin a fit for your round?

Upload your pitch deck and see whether Michael Martin appears in your top 20 matches.